Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-23 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Grant or award +158 21,422
2026-02-17 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −2,041 $331.96 $678K 21,264
2026-02-13 Garg Pushkal EVP Chief R&D Sale −2,242 $310.08 $695K 24,848
2026-02-13 Greenstreet Yvonne Chief Executive Officer Sale −6,958 $310.08 $2.2M 85,662
2026-02-13 Tanguler Tolga EVP, Chief Commercial Officer Sale −1,959 $310.08 $607K 31,769
2026-02-13 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −1,959 $310.08 $607K 23,305
2026-02-13 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −2,242 $310.08 $695K 59,802
2026-02-12 Garg Pushkal EVP Chief R&D Grant or award +4,579 27,090
2026-02-12 Greenstreet Yvonne Chief Executive Officer Grant or award +14,209 92,620
2026-02-12 Tanguler Tolga EVP, Chief Commercial Officer Grant or award +4,000 33,728
2026-02-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Grant or award 10b5-1 +4,000 25,264
2026-02-12 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award +4,579 62,044
2026-01-13 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −197 $367.52 $72K 23,357
2026-01-13 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −562 $368.76 $207K 22,795
2026-01-13 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −644 $370.00 $238K 22,151
2026-01-13 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −485 $371.24 $180K 21,666
2026-01-13 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −280 $372.93 $104K 21,386
2026-01-13 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −122 $374.33 $46K 21,264
2026-01-12 Garg Pushkal EVP Chief R&D Sale −39 $353.95 $14K 23,982
2026-01-12 Garg Pushkal EVP Chief R&D Sale −42 $355.16 $15K 23,940

Page 10 of 41 · 816 trades